BAI Antibodies

Santa Cruz Biotechnology features a diverse variety of BAI Antibodies for targeting Brain-specific Angiogenesis Inhibitor proteins. Monoclonal BAI Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BAI proteins regulate angiogenesis and maintain the integrity of the blood-brain barrier, making them significant in studies related to neurovascular health and disease. Understanding BAI protein function has revealed important roles in neuronal development and response to injury. Research has demonstrated BAI protein involvement in cellular adhesion and signaling pathways within the central nervous system. Ongoing studies continue to uncover new functions of BAI proteins in brain development and neurological conditions. Advanced research techniques have highlighted BAI proteins as potential therapeutic targets in various neurological disorders. The high-quality monoclonal BAI Antibodies from Santa Cruz Biotechnology enable researchers worldwide to make meaningful contributions to neuroscience and vascular biology research.